Terminology Service for NFDI4Health
All terms in MESH
| Label | Id | Description |
|---|---|---|
| 9-(2-fluorobenzyl)-6-(methylamino)-9H-purine | C050493 | |
| Wy 44329 | C050494 | |
| N(10)-propargylfolic acid | C050495 | |
| 3-((benzyloxy)methyl)morpholine | C050496 | |
| spirohydantoin aziridine | C050497 | |
| Web Archive | D000078942 | [Collection of preserved web pages.] |
| N,N-dimethyl-2-((4'-(thien-2''-yl)pyrimidin-2'-yl)thio)ethylamine | C050498 | |
| N-(2''-(dimethylamino)ethyl)-4-(thien-2'-yl)pyrimidin-2-amine | C050499 | |
| Staphylococcus hominis | D041181 | [A species of STAPHYLOCOCCUS similar to STAPHYLOCOCCUS HAEMOLYTICUS, but containing different esterases. The subspecies Staphylococcus hominis novobiosepticus is highly virulent and novobiocin resistant.] |
| glycylpeptide N-tetradecanoyltransferase | C050480 | |
| antithrombin III Denver | C050481 | |
| Rpl19 protein, rat | C050482 | |
| 32-hydroxy-24,25-dihydrolanosterol | C050483 | |
| lactogangliotetraosylceramide | C050484 | |
| fluorescein mono-p-guanidinobenzoate | C050485 | |
| Pharmacopoeia, Homeopathic | D000078930 | [Authoritative resource describing the composition, properties, manufacture, and quality control of HOMEOPATHIC REMEDIES.] |
| Pharmacopeia | D019539 | [Authoritative work containing lists of drugs and preparations, their description, formulation, analytic composition, main chemical properties, standards for strength, purity, and dosage, chemical tests for determining identity, etc. They have the status of a standard.] |
| 5-amino-1,2-dimethylimidazole | C050486 | |
| 4-hydroxymofebutazone | C050487 | |
| sapropel | C050488 |